EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Hepatology Research

ISSN 1386-6346 · Wiley

Neueste Artikel

  1. Statin Use Is Associated With Improved Survival But Not Progression‐Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab–Bevacizumab

    Toshinori Toyota, Satoshi Narahara, Haruki Uojima, Yuki Kitano, Takahiro Mizuta, Daiki Maeda, Soutarou Kurano, Kentaro Tanaka, Hiroki Inada, Munenori Honda, Yoko Yoshimaru, Takehisa Watanabe, Katsuya Nagaoka, Hiroko Setoyama, Hiromitsu Hayashi, Takanori Suzuki, Kentaro Matsuura, Shuichiro Iwasaki, Nao Nomura, Shiho Miyase, Hideto Yuruki, Yoshinari Sakai, Koichi Kudo, Hisashi Hidaka, Masaaki Iwatsuki, Yasuhito Tanaka

    Erschienen: 2026-11DOI: 10.1111/hepr.70232

  2. Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

    Emi Sometani, Kazuhiro Murai, Hayato Hikita, Jihyun Sung, Satoshi Muraoka, Hidenori Toyoda, Satoshi Tanaka, Takayuki Miyake, Shinji Kuriki, Kenji Fukumoto, Satoshi Shigeno, Yuta Myojin, Kazuki Maesaka, Kumiko Shirai, Yuki Makino, Yuki Tahata, Yoshinobu Saito, Takahiro Kodama, Ryotaro Sakamori, Jun Adachi, Tomomi Yamada, Tetsuo Takehara

    Erschienen: 2026-11DOI: 10.1111/hepr.70234

  3. Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative‐Intent Local Treatment for Recurrent Hepatocellular Carcinoma

    Katsunori Sakamoto, Tomoaki Yoh, Satoshi Nomura, Kentaro Kadono, Hidenobu Kojima, Asahi Sato, Shoichi Kageyama, Hirofumi Hirao, Takahiro Nishio, Shinya Okumura, Daisuke Ueda, Masayuki Okuno, Hiroto Nishino, Kei Yamane, Masaaki Hirata, Satoshi Ogiso, Tatsuya Okamoto, Kazuyuki Nagai, Yoichiro Uchida, Takashi Ito, Takamichi Ishii, Etsuro Hatano

    Erschienen: 2026-11DOI: 10.1111/hepr.70235

  4. Simplified BALAD (BALAD‐S) Score as a Guide for First‐Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma

    Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hidenori Toyoda, Chikara Ogawa, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Hironori Tanaka, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Yoshihide Ueda, Soo Ki Kim, Shintaro Takaki, Fujimasa Tada, Hideko Ohama, Shinichiro Nakamura, Takanori Matsuura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita

    Erschienen: 2026-11DOI: 10.1111/hepr.70239

  5. Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow‐Up

    Akihito Takeuchi, Atsumasa Komori, Kazuhito Kawata, Osamu Yoshida, Kazunari Tanaka, Kazumichi Abe, Yukihisa Fujinaga, Tadashi Namisaki, Naruhiro Kimura, Tomohiro Katsumi, Ryo Miura, Naoko Tachizawa, Yoshinari Asaoka, Yoshiyuki Ueno, Shuji Terai, Hiromasa Ohira, Hitoshi Yoshiji, Kentaro Kikuchi, Takeshi Matsui, Tadashi Ikegami, Akira Honda, Masanori Abe, Atsushi Tanaka

    Erschienen: 2026-11DOI: 10.1111/hepr.70246

  6. Preventive Effect of Mineralocorticoid Receptor Antagonists Against Proteinuria Induced by Atezolizumab Plus Bevacizumab Therapy in Hepatocellular Carcinoma: A Multicenter Retrospective Study

    Tomoki Hori, Kazuhiro Yamamoto, Hiroshi Aoi, Yusuke Koizumi, Makoto Kuromatsu, Aiko Fukui, Hiroyo Okamoto, Atsushi Hirata, Kentaro Shinmori, Yuki Imanaka, Miyu Namba, Keisuke Nakanishi, Syunsuke Kitamura, Hideo Tsushima, Ikuko Yano, Kei Moriya, Masaru Matsui, Shigeki Ikushima

    Erschienen: 2026-08DOI: 10.1111/hepr.70176

Jahrgänge

2026 · 1642025 · 2242024 · 1422023 · 1212022 · 1192021 · 1392020 · 1432019 · 1652018 · 1752017 · 1882016 · 1952015 · 1832014 · 2312013 · 1642012 · 1542011 · 1532010 · 1592009 · 1562008 · 1792007 · 2372006 · 1552005 · 1962004 · 1672003 · 1922002 · 1502001 · 1072000 · 691999 · 831998 · 941997 · 157

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.